Article Information
History
- January 5, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Montaser F. Shaheen1,2,*,†,
- Julie Y. Tse3,*,†,
- Ethan S. Sokol3,
- Margaret Masterson4,5,
- Pranshu Bansal6,7,
- Ian Rabinowitz6,7,
- Christy A. Tarleton6,8,
- Andrey S. Dobroff6,8,
- Tracey L. Smith9,10,
- Thèrése J. Bocklage6,11,
- Brian K. Mannakee1,12,
- Ryan N. Gutenkunst1,13,
- Joyce E. Bischoff14,15,
- Scott A. Ness6,8,
- Gregory M. Riedlinger4,16,
- Roman Groisberg4,17,
- Renata Pasqualini9,10,†,
- Shridar Ganesan4,17,*,‡ and
- Wadih Arap6,18,*,‡
- 1University of Arizona Cancer Center; Tucson, AZ 85719
- 2Division of Hematology/Oncology, Department of Medicine, University of Arizona College of Medicine; Tucson, AZ 85724
- 3Foundation Medicine, Inc.; Cambridge, MA 02141
- 4Rutgers Cancer Institute of New Jersey; New Brunswick, NJ 08901
- 5Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; New Brunswick, NJ 08901
- 6University of New Mexico Comprehensive Cancer Center; Albuquerque, NM 87131
- 7Division of Hematology/Oncology, Department of Internal Medicine, University of New Mexico School of Medicine; Albuquerque, NM 87131
- 8Division of Molecular Medicine, Department of Internal Medicine, University of New Mexico School of Medicine; Albuquerque, NM 87131
- 9Rutgers Cancer Institute of New Jersey; Newark, NJ 07103
- 10Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School; Newark, NJ 07103
- 11Department of Pathology, University of Kentucky College of Medicine and Markey Cancer Center; Lexington, KY 40536
- 12Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona; Tucson, AZ 85724
- 13Department of Molecular and Cellular Biology, College of Science, University of Arizona; Tucson, AZ 85721
- 14Vascular Biology Program, Boston Children’s Hospital; Boston, MA 02115
- 15Department of Surgery, Harvard Medical School; Boston, MA 02115
- 16Department of Pathology, Rutgers Robert Wood Johnson Medical School; New Brunswick, NJ 08901
- 17Division of Medical Oncology, Department of Medicine, Rutgers Robert Wood Johnson Medical School; New Brunswick, NJ 08901
- 18Division of Hematology/Oncology, Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103
- ↵*Corresponding authors. Correspondence should be addressed to Dr. Wadih Arap, 185 South Orange Ave. B-1121, Newark, NJ 07103, phone: 973-972-0366, E-mail: wadih.arap{at}rutgers.edu; Dr. Montaser F. Shaheen, E-mail: shaheenm{at}email.arizona.edu; Dr. Julie Y. Tse, E-mail: jtse{at}foundationmedicine.com; or Dr. Shridar Ganesan, E-mail: ganesash{at}cinj.rutgers.edu.
↵† Montaser F. Shaheen and Julie Y. Tse contributed equally to this work.
Posted January 05, 2022.
Genomic Landscape of Lymphatic Malformations: A Case Series and Response to the PI3Kα Inhibitor Alpelisib in an N-of-One Clinical Trial
